Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001282930-05-000017
Filing Date
2005-03-03
Accepted
2005-03-03 13:02:28
Documents
1
Period of Report
2005-03-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 3059
  Complete submission text file 0001282930-05-000017.txt   4851
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1510 STICKNEY POINT RD SARASOTA FL 34231
Business Address 9419268223
SHERRILL JOSEPH H JR (Reporting) CIK: 0001095864 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-23186 | Film No.: 05657014